Last checked at 1 Jun 2018 08:01
1 June 2018
ACCROL GROUP HOLDINGS PLC(AIM: ACRL)
Directors' Dealings
Accrol Group Holdings plc ("Accrol" or the "Company"), the leading independent tissue converter in the UK, is pleased to announce that certain directors of Accrol have, pursuant to the placing to raise £8.0 million (before expenses) described in the Company's announcement of 15 May 2018 titled "Proposed Placing to raise £8 million", in aggregate purchased 2,133,332 ordinary shares of £0.001 each ("Ordinary Shares") at a price of 15p per Ordinary Share as set out below.
Name |
Title |
Number of Shares |
Value of Shares |
Resulting Shareholding | Percentage of Enlarged Share Capital |
|
|
|
|
|
|
Daniel Wright | Executive Chairman | 1,333,333 | £200,000 | 1,748,501 | 0.96% |
Gareth Jenkins | Chief Executive Officer | 500,000 | £75,000 | 600,000 | 0.33% |
Martin Leitch | Interim Chief Financial Officer | 266,666 | £40,000 | 266,666 | 0.15% |
Joanne Lake | Non-executive Director | 33,333 | £5,000 | 68,333 | 0.04% |
The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
1 | Details of the person discharging managerial responsibilities / person closely associated | ||
a) | Name | i) Dan Wright ii) Gareth Jenkins iii) Martin Leitch iv) Joanne Lake | |
2 | Reason for the notification | ||
a) | Position/status | i) Executive Chairman ii) Chief Executive Officer iii) Chief Financial Officer iv) Non-executive Director | |
b)
| Initial notification /Amendment | Initial notification | |
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
a) | Name | Accrol Group Holdings plc | |
b) | LEI | 213800MC56M5G69RJ226 | |
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
a)
| Description of the financial instrument, type of instrument Identification code | Ordinary shares of £0.001
ISIN: GB00BZ6VT592 | |
b) | Nature of the transaction | Purchase of Ordinary Shares | |
c) | Price(s) and volume(s) | Price(s) 15p
| Volume(s) i) 1,333,333 ii) 500,000 iii) 266,666 iv) 33,333
|
d) | Aggregated information - Aggregated volume - Price | N/A - single transaction | |
e) | Date of the transaction | 1 June 2017 | |
f) | Place of the transaction | London Stock Exchange, AIM | |
Enquiries:
Zeus Capital Limited (Nominated Adviser & Broker) |
|
Dan Bate / Andrew Jones | Tel: +44 (0) 161 831 1512 |
Dominic King / John Goold | Tel: +44 (0) 203 829 5000 |
|
|
Belvedere Communications Limited |
|
Cat Valentine (cvalentine@belvederepr.com) | Mob: +44 (0) 7715 769 078 |
Notes to Editors
Accrol Group Holdings plc, based in Lancashire, is a leading tissue converter and supplier of toilet rolls, kitchen rolls and facial tissues as well as other tissue products to major retailers throughout the UK.
Accrol operates from three sites:
· A manufacturing, storage and distribution facility in Blackburn;
· A facial tissue plant, also in Blackburn; and
· A manufacturing, storage and distribution facility in Leyland.